A citation-based method for searching scientific literature

S Michie, J A Smith, J Heaversedge, S Read. J Genet Couns 1999
Times Cited: 9







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Genetic risk and behavioural change.
T M Marteau, C Lerman. BMJ 2001
216
22


Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
W Burke, M Daly, J Garber, J Botkin, M J Kahn, P Lynch, A McTiernan, K Offit, J Perlman, G Petersen,[...]. JAMA 1997
698
22

Population screening in the age of genomic medicine.
Muin J Khoury, Linda L McCabe, Edward R B McCabe. N Engl J Med 2003
244
22

Certainty and uncertainty in genetic counselling: a qualitative case study.
J A Smith, S Michie, A Allanson, R Elwy. Psychol Health 2000
19
22




Nondirectiveness in genetic counseling: an empirical study.
S Michie, F Bron, M Bobrow, T M Marteau. Am J Hum Genet 1997
104
11

Resistance and adherence to the norms of genetic counseling.
F Brunger, A Lippman. J Genet Couns 1995
26
11



Letter to the Editor: Emotional Rescue.
S Kessler. J Genet Couns 2000
1
100



New molecular techniques for chromosome analysis.
E Pergament. Baillieres Best Pract Res Clin Obstet Gynaecol 2000
8
12


The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.
I Martinelli, P Bucciarelli, M Margaglione, V De Stefano, G Castaman, P M Mannucci. Br J Haematol 2000
96
11

Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis.
G Meyer, J Emmerich, D Helley, E Arnaud, V Nicaud, M Alhenc-Gelas, M Aiach, A Fischer, H Sors, J N Fiessinger. Am J Med 2001
32
11

Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC).
P Niccoli-Sire, A Murat, E Baudin, J F Henry, C Proye, J C Bigorgne, B Bstandig, E Modigliani, S Morange, M Schlumberger,[...]. Eur J Endocrinol 1999
69
11

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999
919
11

Prenatal diagnosis and screening of the haemoglobinopathies.
A Cao, R Galanello, M C Rosatelli. Baillieres Clin Haematol 1998
51
11



Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
J L Hopper, M C Southey, G S Dite, D J Jolley, G G Giles, M R McCredie, D F Easton, D J Venter. Cancer Epidemiol Biomarkers Prev 1999
221
11

Hereditary hemochromatosis: presentation and diagnosis in the 1990s.
B R Bacon, S A Sadiq. Am J Gastroenterol 1997
63
11

Online medical genetics resources: a UK perspective.
A Stewart, N Haites, P Rose. BMJ 2001
7
14

American College of Medical Genetics consensus statement on factor V Leiden mutation testing.
W W Grody, J H Griffin, A K Taylor, B R Korf, J A Heit. Genet Med 2001
106
11

A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.
S Middeldorp, J R Meinardi, M M Koopman, E C van Pampus, K Hamulyák, J van Der Meer, M H Prins, H R Büller. Ann Intern Med 2001
136
11

Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.
Ernest Beutler, Vincent J Felitti, James A Koziol, Ngoc J Ho, Terri Gelbart. Lancet 2002
616
11

Will genetics revolutionize medicine?
N A Holtzman, T M Marteau. N Engl J Med 2000
255
11

Online medical genetics resources: a US perspective.
R A Pagon, L Pinsky, C C Beahler. BMJ 2001
14
11


The 22q11.2 deletion: from diversity to a single gene theory.
H P De Decker, J B Lawrenson. Genet Med 2001
15
11


Multiple endocrine neoplasias.
A O Hoff, G J Cote, R F Gagel. Annu Rev Physiol 2000
51
11

Breast cancer susceptibility genes. BRCA1 and BRCA2.
L C Brody, B B Biesecker. Medicine (Baltimore) 1998
105
11

Disorders of iron metabolism.
N C Andrews. N Engl J Med 1999
11

Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons.
A Asberg, K Hveem, K Thorstensen, E Ellekjter, K Kannelønning, U Fjøsne, T B Halvorsen, H B Smethurst, E Sagen, K S Bjerve. Scand J Gastroenterol 2001
224
11

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
11


Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net!
D M McDonald-McGinn, M K Tonnesen, A Laufer-Cahana, B Finucane, D A Driscoll, B S Emanuel, E H Zackai. Genet Med 2001
202
11

Contribution of different HFE genotypes to iron overload disease: a pooled analysis.
W Burke, G Imperatore, S M McDonnell, R C Baron, M J Khoury. Genet Med 2000
61
11


Population-based study of risk of breast cancer in carriers of BRCA2 mutation.
S Thorlacius, J P Struewing, P Hartge, G H Olafsdottir, H Sigvaldason, L Tryggvadottir, S Wacholder, H Tulinius, J E Eyfjörd. Lancet 1998
267
11


Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review.
A Ashley-Koch, Q Yang, R S Olney. Am J Epidemiol 2000
298
11




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.